ACCESSION: MSBNK-SMB_Measured-HSA014P0420001
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 32
COMMENT: RAW_SPEC {'EL07-neg_8909': {'bp': 295815.0, 'sum': 399996.0}, 'EL11-neg_8891': {'bp': 175326.0, 'sum': 259702.0}, 'EL18-neg_8907': {'bp': 138896.0, 'sum': 213657.0}, 'EL10-neg_8868': {'bp': 114720.0, 'sum': 181023.0}, 'EL07-neg_8877': {'bp': 112502.0, 'sum': 165237.0}, 'EL03-neg_8867': {'bp': 110396.0, 'sum': 170074.0}, 'EL06-neg_8909': {'bp': 106533.0, 'sum': 154885.0}, 'EL05-neg_8916': {'bp': 93444.0, 'sum': 149697.0}, 'EL18-neg_8873': {'bp': 88689.0, 'sum': 132925.0}, 'EL11-neg_8858': {'bp': 87520.0, 'sum': 127496.0}, 'EL08-neg_8908': {'bp': 85026.0, 'sum': 127951.0}, 'EL01-neg_8865': {'bp': 81663.0, 'sum': 122297.0}, 'EL22-neg_8934': {'bp': 80923.0, 'sum': 116978.0}, 'EL09-neg_8880': {'bp': 79963.0, 'sum': 133634.0}, 'EL17-neg_8892': {'bp': 79362.0, 'sum': 115925.0}, 'EL02-neg_8954': {'bp': 73121.0, 'sum': 115624.0}, 'EL08-neg_8876': {'bp': 70654.0, 'sum': 104689.0}, 'EL09-neg_8914': {'bp': 69974.0, 'sum': 107887.0}, 'EL14-neg_8875': {'bp': 69633.0, 'sum': 116172.0}, 'EL24-neg_8854': {'bp': 68674.0, 'sum': 103405.0}, 'EL16-neg_8873': {'bp': 66985.0, 'sum': 113152.0}, 'EL23-neg_8879': {'bp': 59353.0, 'sum': 97975.0}, 'EL21-neg_8896': {'bp': 55607.0, 'sum': 106004.0}, 'EL20-neg_8896': {'bp': 54140.0, 'sum': 87548.0}, 'EL19-neg_8931': {'bp': 52711.0, 'sum': 107304.0}, 'EL04-neg_8868': {'bp': 45732.0, 'sum': 77227.0}, 'EL17-neg_8925': {'bp': 43404.0, 'sum': 77059.0}, 'EL01-neg_8896': {'bp': 40189.0, 'sum': 78570.0}, 'EL12-neg_8927': {'bp': 39642.0, 'sum': 61375.0}, 'EL13-neg_8887': {'bp': 35245.0, 'sum': 63038.0}, 'EL10-neg_8904': {'bp': 35069.0, 'sum': 64421.0}, 'EL06-neg_8945': {'bp': 29841.0, 'sum': 69662.0}}
COMMENT: RETENTION_TIME_STDEV 0.024
COMMENT: PRECURSOR_M/Z_RAW 420.250412
COMMENT: PRECURSOR_M/Z_STDEV 0.000196
COMMENT: PRECURSOR_IN_MS1 mz 420.250290; int 57.700; delta(ppm) 0.931672
COMMENT: PROPOSED_CHARGE_STATE -1; mz 421.253550; int 14.066; cor 0.927
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+FA-H; M-H; mz 374.244693; int 22.068; cor 0.920
COMMENT: PROPOSED_ION_FORM M+FA-H; M+Cl; mz 410.221463; int 6.863; cor 0.886
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 4.071; C20H40NO6P; [M-H]1; delta(ppm) -4.071143
COMMENT: PROPOSED_MF SevenGoldenRules 1.617; C14H41N5O5P2; [M-H]1; delta(ppm) -1.616588
COMMENT: PROPOSED_MF SevenGoldenRules 0.150; C22H35N3O5; [M-H]1; delta(ppm) -0.149552
COMMENT: PROPOSED_MF SevenGoldenRules 4.565; C19H38NO4P; [M+FA-H]1; delta(ppm) -4.564931
COMMENT: PROPOSED_MF SevenGoldenRules 1.809; C13H39N5O3P2; [M+FA-H]1; delta(ppm) -1.809450
COMMENT: PROPOSED_MF SevenGoldenRules 0.163; C21H33N3O3; [M+FA-H]1; delta(ppm) -0.162557
COMMENT: CONFIDENCE Level 5: Exact mass of interest 420.250332; Observed in MS1; Charge state -1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 15.253
MS$FOCUSED_ION: PRECURSOR_M/Z 420.250332
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-0009000000-e860b9168999f7aa59d0
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  374.2447067 999.0000 ? 374.245180 0.4008 0.00 0.9551 32
  375.2479061 220.4888 ? 375.248380 1.3165 25.95 1.0000 28
PK$NUM_PEAK: 2
PK$PEAK: m/z int. rel.int.
  374.244707 999.00 999
  375.247906 220.49 220
//
